Lung segmentectomy after chemo or immunotherapy
Part of Cancer, Lungs & breathing clinical trials.
This study tests a type of lung surgery called segmentectomy for people whose lung cancer shrank after chemotherapy or immunotherapy. The goal is to see if removing just the tumor part is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have non-small cell lung cancer that shrunk to 3 cm or smaller after chemotherapy or immunotherapy.
- You are 18 years or older and in fairly good health (ECOG score less than 3).
- Your lung function is good enough for surgery (breathing tests at least 40% of normal).
- You have not had lung surgery before and are not currently smoking (or quit at least 4 weeks ago).
- You have no other active cancer (except some minor skin cancers) and no uncontrolled serious illnesses.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of lung surgery for early-stage lung cancer: removing only the tumor part (segmentectomy) versus removing a larger portion (lobectomy). The goal is to see if the less invasive surgery works just as well while preserving more healthy lung tissue.
This trial compares two surgical approaches for advanced lung cancer (stage IIA-IIIB) after patients have already received immunotherapy and chemotherapy. Researchers want to see if removing a smaller portion of the lung (sub-lobectomy) works as well as removing an entire lobe (lobectomy), potentially reducing side effects while fighting cancer.
This trial tests whether combining chemo or targeted therapy before surgery can help people with non-small cell lung cancer that may require removing a whole lung. We want to see if this approach makes the surgery safer and more effective.
This study looks at whether doing surgery after immunotherapy (with or without chemo) can be less invasive than originally planned. If your lung cancer shrunk enough after treatment that you might need a smaller surgery than first thought, this trial could help find the best approach.
This trial tests giving chemotherapy, immunotherapy, and targeted radiation before surgery for people with non-small cell lung cancer that can be removed. The goal is to see if this combination shrinks tumors and improves outcomes.
This study compares two types of lung surgery for people with early-stage non-small cell lung cancer (a common type of lung cancer). One surgery removes a small part of the lung (segment), the other removes an entire lobe (a larger section of the lung). The goal is to see which approach offers better outcomes for tumors that are between 2 and 3 centimeters across and are solid (not just ground-glass).
Hear when a new Segmentectomy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.